Contemporary Pediatrics
186 FOLLOWERS
MD Magazine is the preeminent destination for physicians, pharmacists, managed care executives and other healthcare professionals who are looking for tools, techniques and information that can help them provide better care. Keep up with news on Pediatrics from MD Magazine.
Contemporary Pediatrics
1w ago
IXINITY is now approved to treat all patients with the hemophilia B to help control bleeding episodes, as well as reduce the frequency of them ..read more
Contemporary Pediatrics
1w ago
If approved, govorestat would be the first medication indicated for the treatment of galactosemia, a rare genetic metabolic disease resulting in an inability to metabolize simple sugar galactose ..read more
Contemporary Pediatrics
1w ago
Tenofovir alafenamide was approved in 2022 to treat pediatric patients aged 12 years and older ..read more
Contemporary Pediatrics
1w ago
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed ..read more
Contemporary Pediatrics
1w ago
NeuroStar Advanced Therapy becomes the first and only transcranial magnetic stimulation therapy cleared by the FDA as an adjunct treatment for patients 15 years and up with depression ..read more
Contemporary Pediatrics
1w ago
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the April 2024 issue of Contemporary Pediatrics ..read more
Contemporary Pediatrics
1w ago
A discussion of human trafficking awareness and what primary care providers can do to spot red flags and implement evidence-based knowledge ..read more
Contemporary Pediatrics
1w ago
Chris Kyper, DNP, CPNP-AC/PC, breaks down characteristics of Heparin-induced thrombocytopenia, an uncommon adverse reaction to heparin ..read more
Contemporary Pediatrics
1w ago
The planned phase 1/2 INSPIRE Duchenne trial (NCT06138639) is a first in-human, open-label, multicenter trial to evaluate tolerability and safety of SGT-003 ..read more